Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Study Links Heavy Cannabis Use To Higher Death Risk, Psychosis

Heavy weed use may be far more dangerous than people realize, according to a pair of studies published in JAMA Network Open. People diagnosed with cannabis use

Texas County Reports Measles Outbreak Among Unvaccinated Children

The Texas Department of State Health Services (DSHS) is reporting an outbreak of measles in Gaines County. All cases have been identified among unvaccinated sch

Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers

Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involve

Wildfires Can Raise Rates of Heart Attacks, Deaths

With Los Angeles still reeling from the devastating Palisades and Eaton fires, a new report on California blazes from earlier years finds the toll on survivors

Firstborn's Trauma Could Set Stage for Mental Health of Younger Kids

Trauma experienced by the oldest child in a family does not bode well for their younger siblings, new British data suggest. A child s odds for developing mental

'Ozempic Face' and Other Top Trends in Plastic Surgery

Add surgical tweaks to fix so-called Ozempic face to the list of top trending cosmetic procedures, as tallied by the American Academy of Facial Plastic and Reco

ER Visits for Burns, Eye Issues Rose 8-Fold During Recent L.A. Fires

Los Angeles County residents are still recovering from the devastation of the Palisades and Eaton fires, and new data show that emergency department (ED) visits

EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of Duravyu for Diabetic Macular Edema Meeting Primary and Secondary Endpoints

EyePoint Pharmaceuticals, Inc. (NASDAQ EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients wit

Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease

via IBN Annovis Bio Inc. (NYSE ANVS) ( Annovis or the Company ), a late-stage clinical drug platform company pioneering transformative therapies for neurodegene

Arbor Biotechnologies Announces FDA Orphan Drug and Rare Pediatric Disease Designations Granted to ABO-101 for the Treatment of Primary Hyperoxaluria Type 1 (PH1)

CAMBRIDGE, MA February 5, 2025 Arbor Biotechnologies , a biotechnology company discovering and developing the next generation of genetic medicines, today announ

Popular Keywords